Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
Clinical trial NCT02904954 · COMPLETED
Trial details
- NCT number
- NCT02904954
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-02
- Primary completion
- 2020-09-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.